- The 40 million euros loan is intended for the development of treatments based on MedinCell’s proprietary long-acting injectable technology aiming at significantly enhance patient care and quality of life
Contacts
France : EIB and MedinCell sign a new €40 million loan agreement to support development of innovative treatments
November 23, 2022